{"product_id":"bhil-vrio-analysis","title":"Benson Hill, Inc. (BHIL): VRIO Analysis [Mar-2026 Updated]","description":"\u003cbr\u003e\u003cp\u003eUnlocking the secrets to Benson Hill, Inc. (BHIL)'s market position starts here: this concise VRIO analysis cuts straight to the chase, examining if its core assets are truly Valuable, Rare, Inimitable, and Organized to forge a sustainable competitive edge. Discover the distilled summary of what truly drives Benson Hill, Inc. (BHIL)'s performance and why it matters - read on to see the full breakdown!\u003c\/p\u003e\n\n\u003cbr\u003e\u003ch2\u003eBenson Hill, Inc. (BHIL) - VRIO Analysis: 1. Proprietary Seed Genetics \u0026amp; Trait Pipeline\n\u003c\/h2\u003e\n\u003cp\u003eYou’re looking at the core engine that drove the asset sale to Confluence Genetics: the specialized soybean germplasm and breeding technology. This pipeline is what makes the new entity a focused player, not just another commodity trader.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eValue: Delivers differentiated, high-value soybeans (like UHP-LO) that command premium pricing and licensing fees, driving the asset-light revenue model.\u003c\/strong\u003e The proprietary genetics, such as the Ultra High Protein Low Oligosaccharides (UHP-LO) non-GMO varieties, are designed to offer significant economic returns, with estimates suggesting up to \u003cstrong\u003e$2.2 billion\u003c\/strong\u003e in annual value for the broiler industry alone. The focus on quality traits allows for a shift toward higher-margin licensing revenue, a key part of the post-transition strategy.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eRarity: The specific, advanced, non-GMO traits developed are rare, especially those showing yield parity with elite GMO varieties.\u003c\/strong\u003e The ability to achieve a yield gap of only \u003cstrong\u003e3 to 5\u003c\/strong\u003e bushels per acre while delivering a protein gain of \u003cstrong\u003e2%\u003c\/strong\u003e over previous generations is not common in the market. Furthermore, the acquisition included over \u003cstrong\u003e350\u003c\/strong\u003e patents issued or pending, underpinning this uniqueness.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eImitability: High; requires years of R\u0026amp;D, specialized breeding, and field testing to replicate the specific germplasm and trait stacks.\u003c\/strong\u003e Replicating this requires deep investment in R\u0026amp;D, AI-driven platforms like CropOS®, and extensive field testing across maturity zones. The 2029 soybean class, for instance, was only recently planted in \u003cstrong\u003e2025\u003c\/strong\u003e field trials, showing the long lead time needed to bring new traits to market.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eOrganization: High; the pipeline was actively managed, with over 350 patents acquired and the 2029 class already in 2025 field trials.\u003c\/strong\u003e Despite the Chapter 11 filing, the strategic value was recognized in the May 2025 asset sale, confirming the structure was sound enough to be acquired by Confluence Genetics to continue scaling. The company expected to plant its genetics on more than \u003cstrong\u003e450,000\u003c\/strong\u003e acres in 2025, indicating operational readiness for commercialization.\u003c\/p\u003e\n\n\u003cp\u003eHere’s the quick math on the competitive standing based on these dimensions:\u003c\/p\u003e\n\u003ctable border=\"1\"\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eVRIO Dimension\u003c\/td\u003e\n    \u003ctd\u003eAssessment\u003c\/td\u003e\n    \u003ctd\u003eScore (1=No, 2=Yes)\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eValue\u003c\/td\u003e\n    \u003ctd\u003eYes, creates significant economic benefit (e.g., \u003cstrong\u003e$2.2B\u003c\/strong\u003e potential value).\u003c\/td\u003e\n    \u003ctd\u003e\u003cstrong\u003e2\u003c\/strong\u003e\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eRarity\u003c\/td\u003e\n    \u003ctd\u003eYes, unique non-GMO traits with near-parity yield and \u003cstrong\u003e350+\u003c\/strong\u003e patents.\u003c\/td\u003e\n    \u003ctd\u003e\u003cstrong\u003e2\u003c\/strong\u003e\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eInimitability\u003c\/td\u003e\n    \u003ctd\u003eYes, high cost\/time barrier due to R\u0026amp;D and germplasm library.\u003c\/td\u003e\n    \u003ctd\u003e\u003cstrong\u003e2\u003c\/strong\u003e\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eOrganization\u003c\/td\u003e\n    \u003ctd\u003eYes, assets acquired and focused on scaling the pipeline (e.g., \u003cstrong\u003e2029\u003c\/strong\u003e class in trials).\u003c\/td\u003e\n    \u003ctd\u003e\u003cstrong\u003e2\u003c\/strong\u003e\u003c\/td\u003e\n  \u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cp\u003e\u003cstrong\u003eCompetitive Advantage: Sustained; the core genetic library and pipeline are the foundation of the new entity's focus.\u003c\/strong\u003e The combination of V=2, R=2, I=2, and O=2 points directly to a \u003cstrong\u003eSustained Competitive Advantage\u003c\/strong\u003e. What this estimate hides is the immediate operational risk following the bankruptcy, but the asset itself remains strong.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eTraits include \u003cstrong\u003e2%\u003c\/strong\u003e protein gain.\u003c\/li\u003e\n\u003cli\u003eYield gap is only \u003cstrong\u003e3-5\u003c\/strong\u003e bu\/acre vs. GMOs.\u003c\/li\u003e\n\u003cli\u003ePortfolio expected to reach over \u003cstrong\u003e35\u003c\/strong\u003e varieties by 2025.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e2029\u003c\/strong\u003e class planted in \u003cstrong\u003e2025\u003c\/strong\u003e trials.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFinance: draft 13-week cash view by Friday.\u003c\/p\u003e\n\n\u003cbr\u003e\u003ch2\u003eBenson Hill, Inc. (BHIL) - VRIO Analysis: 2. CropOS® Technology Platform\n\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eValue\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis AI-driven platform speeds up trait discovery and breeding, reducing the time-to-market for new, high-value seed varieties. CropOS is claimed to speed up new variety development to around \u003cstrong\u003efour years\u003c\/strong\u003e, compared to over a decade with conventional techniques. The platform uses powerful data analytics to identify the most promising plant genetics in \u003cstrong\u003eweeks instead of multiple growing seasons\u003c\/strong\u003e. Ultra-high protein (UHP) soybeans developed via CropOS deliver \u003cstrong\u003e50% more protein\u003c\/strong\u003e than conventional soy.\u003c\/p\u003e\n\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\/Context\u003c\/th\u003e\n\u003cth\u003eSource Year\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eTime Reduction (Breeding)\u003c\/td\u003e\n\u003ctd\u003eTo around \u003cstrong\u003efour years\u003c\/strong\u003e from over a decade\u003c\/td\u003e\n\u003ctd\u003e2021\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGenetic Identification Speed\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eWeeks\u003c\/strong\u003e instead of multiple growing seasons\u003c\/td\u003e\n\u003ctd\u003e2016\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eUHP Soybean Protein Content\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003e50% more\u003c\/strong\u003e than conventional soy\u003c\/td\u003e\n\u003ctd\u003e2021\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eYield Drag Reduction (YoY)\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003e45% reduction\u003c\/strong\u003e (2023 harvest data)\u003c\/td\u003e\n\u003ctd\u003e2024\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eProjected 2025 Planted Acres (Genetics)\u003c\/td\u003e\n\u003ctd\u003eMore than \u003cstrong\u003e450,000 acres\u003c\/strong\u003e\n\u003c\/td\u003e\n\u003ctd\u003e2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003e\u003cstrong\u003eRarity\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eModerate to High; while AI in agriculture is growing, the specific application and integration with Benson Hill's germplasm is unique. The platform incorporates a significant proprietary data library.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eProprietary data library size expected to \u003cstrong\u003edouble in size every year\u003c\/strong\u003e (as of May 2021).\u003c\/li\u003e\n\u003cli\u003eData library includes \u003cstrong\u003ehundreds of billions of data points\u003c\/strong\u003e to understand natural genetic variation.\u003c\/li\u003e\n\u003cli\u003eIncorporated \u003cstrong\u003e120,000 unique plant genomes\u003c\/strong\u003e across \u003cstrong\u003e27 species\u003c\/strong\u003e (as of May 2021).\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eImitability\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eModerate; the underlying AI models are complex, but competitors can invest in similar platforms over time. Significant capital investment has been directed toward platform advancement.\u003c\/p\u003e\n\u003cp\u003eSeries D funding round to accelerate CropOS: \u003cstrong\u003e$150 million\u003c\/strong\u003e (2020). Series B funding round to advance CropOS: \u003cstrong\u003e$25 million\u003c\/strong\u003e (2017).\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eOrganization\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHigh; this technology was central to the company's strategy, even as it transitioned away from physical processing. The Crop Accelerator R\u0026amp;D hub enhances CropOS with a \u003cstrong\u003etwenty-fold increase in testing capacity\u003c\/strong\u003e. The company filed for Chapter 11 protection in March 2025, reporting assets of \u003cstrong\u003e$137.5 million\u003c\/strong\u003e and liabilities of \u003cstrong\u003e$110.7 million\u003c\/strong\u003e.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCompetitive Advantage\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTemporary to Sustained; its effectiveness depends on continuous data input and refinement, but it's a key differentiator now. Varieties slated for commercial launch in 2025 are expected to boost protein by another \u003cstrong\u003e2%\u003c\/strong\u003e over the previous generation.\u003c\/p\u003e\n\n\u003cbr\u003e\u003ch2\u003eBenson Hill, Inc. (BHIL) - VRIO Analysis: 3. Ultra-High Protein (UHP) Trait Technology\n\u003c\/h2\u003e\n\u003cp\u003e\nThe analysis below focuses exclusively on real-life statistical and financial data relevant to the UHP Trait Technology component of Benson Hill, Inc.\n\u003c\/p\u003e\n\n\u003ch\u003eValue\u003c\/h\u003e\n\u003cp\u003e\nThe UHP trait directly addresses massive animal feed demand by offering superior protein content, improving feed efficiency for customers.\n\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eUHP soybean contains nearly 50% protein content, compared to roughly 40% crude protein in traditional soybeans.\u003c\/li\u003e\n\u003cli\u003eUHP-LO Soybean Meal (SBM) delivers 14% higher crude protein levels compared to conventional SBM.\u003c\/li\u003e\n\u003cli\u003eWhen formulated for cost advantages, UHP-LO SBM significantly lowered feed costs by increasing protein and higher metabolizable energy.\u003c\/li\u003e\n\u003cli\u003eIn a trial with Tyson Foods, UHP-LO SBM formulation resulted in feed cost savings of up to $0.20 per bird.\u003c\/li\u003e\n\u003cli\u003eOne commercial feeding trial showed replacing commodity SBM with UHP-LO SBM improved broiler weights by 5.4% and feed conversion ratios by 3.2%.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch\u003eRarity\u003c\/h\u003e\n\u003cp\u003e\nUHP-LO varieties represent a specific, validated solution with clear market pull, particularly in animal nutrition.\n\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eUHP-LO SBM has been shown to contain \u0026lt;1% oligosaccharides (as-is).\u003c\/li\u003e\n\u003cli\u003eThe seed development process dramatically lowers anti-nutrient levels, specifically showing 90% fewer oligosaccharides in the soybean itself.\u003c\/li\u003e\n\u003cli\u003eThe company's third generation UHP-LO, non-GMO soybean varieties revealed a 2% increase in protein levels compared to the previous generation.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch\u003eImitability\u003c\/h\u003e\n\u003cp\u003e\nReplicating the specific UHP trait expression with low oligosaccharides is technically challenging, supported by over two decades of breeding.\n\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eData Point\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eBreeding Foundation\u003c\/td\u003e\n\u003ctd\u003eSupported by more than two decades of soybean breeding.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eProtein Yield Increase (from soil)\u003c\/td\u003e\n\u003ctd\u003eAchieving a 20% increase in protein yield directly from the soil, prior to any processing.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEstimated Annual Industry Value\u003c\/td\u003e\n\u003ctd\u003eChoosing specialty soy from Benson Hill can generate approximately $2.2 billion of value annually for the broiler industry.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003ch\u003eOrganization\u003c\/h\u003e\n\u003cp\u003e\nThe company has successfully executed feeding studies with major industry players, demonstrating organizational capability to validate the technology.\n\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eThe company successfully executed feeding studies with major broiler producers representing over 40 percent of the U.S. broiler market [cite: Prompt instruction].\u003c\/li\u003e\n\u003cli\u003eBenson Hill partnered with Tyson Foods for a feeding trial involving more than 800 broilers.\u003c\/li\u003e\n\u003cli\u003eThe company plans to broaden its soybean portfolio to more than 35 varieties for the 2025 crop year.\u003c\/li\u003e\n\u003cli\u003eThe company is targeting Benson Hill genetics to be planted across 6 million domestic acres by 2030.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch\u003eCompetitive Advantage\u003c\/h\u003e\n\u003cp\u003e\nSustained competitive advantage is underpinned by this proven product platform, which is expected to drive near-term licensing revenue.\n\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eThe potential total market value created long-term from Benson Hill genetics in the US soy market for domestic consumption is estimated at $0.7-1.5 billion.\u003c\/li\u003e\n\u003cli\u003eThe projected value creation per acre is between $100 to $230 per acre.\u003c\/li\u003e\n\u003cli\u003eLicensing revenue increased in Q1 2024, contributing to a gross profit of $5.2 million in that quarter, up from $4.6 million in Q1 2023.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cbr\u003e\u003ch2\u003eBenson Hill, Inc. (BHIL) - VRIO Analysis: 4. Intellectual Property Portfolio\n\u003c\/h2\u003e\n\u003cp\u003eThe Intellectual Property (IP) portfolio, which formed a core component of the assets acquired by Confluence Genetics, LLC in May 2025, represents a significant source of potential competitive advantage derived from Benson Hill's technology platform.\u003c\/p\u003e\n\u003ch\u003eValue\u003c\/h\u003e\n\u003cp\u003eProvides a legal moat around the core technology, enabling strong licensing terms and blocking direct competition from using key innovations.\u003c\/p\u003e\n\u003ch\u003eRarity\u003c\/h\u003e\n\u003cp\u003eHigh; the acquisition included more than \u003cstrong\u003e350\u003c\/strong\u003e patents issued or pending as of May 2025.\u003c\/p\u003e\n\u003ch\u003eImitability\u003c\/h\u003e\n\u003cp\u003eVery High; patents are legally protected barriers that competitors cannot easily bypass.\u003c\/p\u003e\n\u003ch\u003eOrganization\u003c\/h\u003e\n\u003cp\u003eHigh; the IP was successfully transferred and is now managed by Confluence Genetics to enforce licensing agreements. The company's strategic focus, prior to the asset sale, included monetizing this IP through several avenues.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eLicensing germplasm to seed companies.\u003c\/li\u003e\n\u003cli\u003eDirect seed and grain sales to farmers.\u003c\/li\u003e\n\u003cli\u003eTechnology access fees and value-based royalties from seed companies, processors and end users.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor context on the technology being protected, Benson Hill had planned to expand its proprietary soybean seed portfolio from \u003cstrong\u003e22\u003c\/strong\u003e to \u003cstrong\u003e35\u003c\/strong\u003e varieties by 2025, as communicated in March 2024.\u003c\/p\u003e\n\u003ch\u003eCompetitive Advantage\u003c\/h\u003e\n\u003cp\u003eSustained; patents offer the strongest form of protection in technology-driven agriculture.\u003c\/p\u003e\n\u003cp\u003eThe VRIO assessment for the Intellectual Property Portfolio is summarized below:\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eVRIO Component\u003c\/th\u003e\n\u003cth\u003eAssessment\u003c\/th\u003e\n\u003cth\u003eData\/Justification Reference\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eValue\u003c\/td\u003e\n\u003ctd\u003eYes\u003c\/td\u003e\n\u003ctd\u003eLegal moat, strong licensing terms, blocking competition.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRarity\u003c\/td\u003e\n\u003ctd\u003eYes\u003c\/td\u003e\n\u003ctd\u003eMore than \u003cstrong\u003e350\u003c\/strong\u003e patents issued or pending as of May 2025.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImitability\u003c\/td\u003e\n\u003ctd\u003eDifficult\/Costly\u003c\/td\u003e\n\u003ctd\u003eLegally protected barriers (patents).\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOrganization\u003c\/td\u003e\n\u003ctd\u003eYes\u003c\/td\u003e\n\u003ctd\u003eSuccessful transfer and management by Confluence Genetics for enforcement.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCompetitive Advantage\u003c\/td\u003e\n\u003ctd\u003eSustained\u003c\/td\u003e\n\u003ctd\u003eStrongest form of protection in technology-driven agriculture.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cbr\u003e\u003ch2\u003eBenson Hill, Inc. (BHIL) - VRIO Analysis: 5. Crop Accelerator Facility (Speed Breeding)\n\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eValue\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe facility provides a \u003cstrong\u003e“more than twenty-fold expansion in testing capacity”\u003c\/strong\u003e for crop development. The technology has the potential to shave years off the traditional crop breeding process.\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003ctd\u003eMetric\u003c\/td\u003e\n\u003ctd\u003eSpeed Breeding (Optimized)\u003c\/td\u003e\n\u003ctd\u003eTraditional Approach (Benchmark)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eGenerations Per Year (Soybean Potential)\u003c\/td\u003e\n\u003ctd\u003eUp to \u003cstrong\u003esix\u003c\/strong\u003e generations per year\u003c\/td\u003e\n\u003ctd\u003eTypically only \u003cstrong\u003e1–3\u003c\/strong\u003e generations per year\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSeed-to-Seed Cycle Time (Soybean)\u003c\/td\u003e\n\u003ctd\u003eAs low as \u003cstrong\u003e63 days\u003c\/strong\u003e\n\u003c\/td\u003e\n\u003ctd\u003eApproximately \u003cstrong\u003e~120 days\u003c\/strong\u003e in field conditions\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003e\u003cstrong\u003eRarity\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe Crop Accelerator is a \u003cstrong\u003e47,000-square-foot\u003c\/strong\u003e research and development facility. It utilizes innovative imaging and automation technology.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eImitability\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe development of the facility was described as a \u003cstrong\u003e$20 million-plus\u003c\/strong\u003e project.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOrganization\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe facility has \u003cstrong\u003e27 employees\u003c\/strong\u003e operating out of it. Since opening in 2021, plant breeders have completed \u003cstrong\u003emore than 200 crop cycles\u003c\/strong\u003e within the facility. The CropOS platform, in conjunction with the Accelerator, advanced \u003cstrong\u003emore than 24,000\u003c\/strong\u003e candidate soybean varieties since 2021.\u003c\/p\u003e\n\u003cp\u003eBenson Hill expects to broaden its soybean portfolio to approximately \u003cstrong\u003e35 varieties by 2025\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCompetitive Advantage\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHerbicide-tolerant Ultra-High Protein Low-Oligosaccharide (UHP-LO) soybean varieties are slated for launch in \u003cstrong\u003e2026\u003c\/strong\u003e, a year sooner than previously communicated.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eThe Company continues to invest in critical technology costs and facilities expenses, primarily related to the Crop Accelerator facility.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cbr\u003e\u003ch2\u003eBenson Hill, Inc. (BHIL) - VRIO Analysis: 6. Strategic Validation and Partner Network\n\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eValue:\u003c\/strong\u003e Third-party validation from major industry players de-risks the technology for future customers and partners, evidenced by cost savings in feeding trials.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eFeeding trial with Tyson Foods confirmed UHP-LO SBM delivered cost savings for poultry producers, reducing feed costs by up to \u003cstrong\u003e$0.20 per bird\u003c\/strong\u003e when formulated for cost advantage.\u003c\/li\u003e\n\u003cli\u003eThe higher crude protein levels in UHP-LO SBM allowed for a reduction in the amount of SBM and fat added to the diet while maintaining necessary protein and energy levels.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eRarity:\u003c\/strong\u003e Moderate; validation across a significant portion of a major market segment is notable.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eTwo additional feeding studies were initiated with major broiler producers who, in total, represent more than \u003cstrong\u003e40 percent of the U.S. broiler market\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eThese studies cover upwards of \u003cstrong\u003e6 million acres\u003c\/strong\u003e of the total \u003cstrong\u003e14 million acres\u003c\/strong\u003e of soy dedicated to broilers.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eImitability:\u003c\/strong\u003e Moderate; securing and executing large-scale trials with major industry players requires established credibility and time.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOrganization:\u003c\/strong\u003e High; the company successfully converted R\u0026amp;D investment into commercial proof points, crucial for the shift to a licensing model.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eR\u0026amp;D expenses for the third quarter of 2024 were \u003cstrong\u003e$7.0 million\u003c\/strong\u003e, representing a decrease of \u003cstrong\u003e33.4 percent\u003c\/strong\u003e compared to the prior year period.\u003c\/li\u003e\n\u003cli\u003eThe company's transition to an asset-light licensing model is supported by these partnerships and the commercialization of innovations like UHP-LO soybeans.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eCompetitive Advantage:\u003c\/strong\u003e Temporary; while partner relationships can shift, the documented performance data is a lasting asset.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eData Point\u003c\/th\u003e\n\u003cth\u003eContext\/Partner\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eMarket Segment Coverage\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003e40 percent\u003c\/strong\u003e of the U.S. broiler segment\u003c\/td\u003e\n\u003ctd\u003eMajor broiler producers involved in Q3 2024 feeding studies.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSoy Acreage Covered\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e6 million acres\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSoy acreage dedicated to broilers covered by current studies.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFeed Cost Reduction\u003c\/td\u003e\n\u003ctd\u003eUp to \u003cstrong\u003e$0.20 per bird\u003c\/strong\u003e\n\u003c\/td\u003e\n\u003ctd\u003eAchieved when formulating for cost advantage using UHP-LO SBM in a Tyson Foods trial.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eQ3 2024 R\u0026amp;D Expense\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$7.0 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eReflects investment in technology driving innovation.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePlanned Turkey Studies\u003c\/td\u003e\n\u003ctd\u003eRepresenting \u003cstrong\u003e4 million acres\u003c\/strong\u003e of soy\u003c\/td\u003e\n\u003ctd\u003ePlanned for Q1 2025 to expand presence in the feed market.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cbr\u003e\u003ch2\u003eBenson Hill, Inc. (BHIL) - VRIO Analysis: 7. Transition to Asset-Light Licensing Focus\n\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eValue: Improved financial quality by shifting revenue from low-margin processing (which led to divestitures) to higher-margin licensing and technology access fees.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eQ1 2024 reported revenues, excluding divested processing assets, were approximately \u003cstrong\u003e$21.1 million\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eQ1 2024 gross profit was \u003cstrong\u003e$5.2 million\u003c\/strong\u003e, compared to \u003cstrong\u003e$4.6 million\u003c\/strong\u003e in the prior year period.\u003c\/li\u003e\n\u003cli\u003eQ1 2024 operating expenses were \u003cstrong\u003e$21.8 million\u003c\/strong\u003e, compared to \u003cstrong\u003e$25.9 million\u003c\/strong\u003e in the prior year period.\u003c\/li\u003e\n\u003cli\u003eQ3 2024 revenues of approximately \u003cstrong\u003e$34.1 million\u003c\/strong\u003e reflected residual grain sales during the transition, compared to \u003cstrong\u003e$23.5 million\u003c\/strong\u003e in Q3 2023.\u003c\/li\u003e\n\u003cli\u003eQ3 2024 Adjusted EBITDA loss was \u003cstrong\u003e$12.6 million\u003c\/strong\u003e, an improvement from a loss of \u003cstrong\u003e$14.4 million\u003c\/strong\u003e in Q3 2023.\u003c\/li\u003e\n\u003cli\u003eR\u0026amp;D expenses decreased by \u003cstrong\u003e33.4 percent\u003c\/strong\u003e, from $10.5 million (implied: $7.0M + $3.5M) to \u003cstrong\u003e$7.0 million\u003c\/strong\u003e in Q3 2024.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eRarity: Low; many companies attempt this shift, but few execute the divestiture of major assets (like the Seymour and Creston facilities) while retaining core IP.\u003c\/strong\u003e\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003ctd\u003eAsset Divested\u003c\/td\u003e\n\u003ctd\u003eDivestiture Date Context\u003c\/td\u003e\n\u003ctd\u003eTransaction Value \/ Debt Retired\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eCreston, Iowa Facility\u003c\/td\u003e\n\u003ctd\u003eAnnounced February 2024\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003e$72 million\u003c\/strong\u003e sale price.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSeymour, Indiana Facility\u003c\/td\u003e\n\u003ctd\u003eOctober last year (relative to Feb 2024)\u003c\/td\u003e\n\u003ctd\u003ePart of strategic restructuring.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDebt Retirement\u003c\/td\u003e\n\u003ctd\u003ePost-Creston Divestiture\u003c\/td\u003e\n\u003ctd\u003eApproximately \u003cstrong\u003e$120 million\u003c\/strong\u003e in high-cost, restrictive debt retired.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003e\u003cstrong\u003eImitability: Low; the execution of the divestitures was unique to the company's specific financial situation.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eSoy processing revenues and associated costs represented approximately \u003cstrong\u003e73 percent\u003c\/strong\u003e of \u003cstrong\u003e2023 revenues and costs of goods sold\u003c\/strong\u003e prior to reclassification.\u003c\/li\u003e\n\u003cli\u003eThe Company secured a commitment of approximately \u003cstrong\u003e$11 million\u003c\/strong\u003e in Debtor-in-Possession financing upon filing for Chapter 11.\u003c\/li\u003e\n\u003cli\u003eThe Company ended Q3 2024 with \u003cstrong\u003e$14.4 million\u003c\/strong\u003e of cash and marketable securities.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eOrganization: Moderate; the organization was clearly structured around this goal, leading to expense reductions, though it ended in bankruptcy.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eVoluntary petitions for relief under Chapter 11 were filed on \u003cstrong\u003eMarch 20, 2025\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eThe bankruptcy cases were converted to Chapter 7 on \u003cstrong\u003eSeptember 23, 2025\u003c\/strong\u003e (or \u003cstrong\u003eSeptember 30, 2025\u003c\/strong\u003e).\u003c\/li\u003e\n\u003cli\u003eCash used in operating activities from continuing operations decreased by \u003cstrong\u003e$24.3 million\u003c\/strong\u003e year-over-year in Q1 2024, from \u003cstrong\u003e$34.5 million\u003c\/strong\u003e used in Q1 2023 to \u003cstrong\u003e$10.2 million\u003c\/strong\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eCompetitive Advantage: Temporary; the model itself is not unique, but the successful retention of IP during the transition is valuable now.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eFor the year ended December 31, 2023, reported revenues were \u003cstrong\u003e$473.3 million\u003c\/strong\u003e, an increase of \u003cstrong\u003e24 percent\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eReported gross profit for FY 2023 was \u003cstrong\u003e$23.6 million\u003c\/strong\u003e, an increase of \u003cstrong\u003e$20.1 million\u003c\/strong\u003e or \u003cstrong\u003e570 percent\u003c\/strong\u003e compared to the prior year.\u003c\/li\u003e\n\u003cli\u003eNet loss from continuing operations for the year ended December 31, 2023, was \u003cstrong\u003e$111.3 million\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eFree cash flow loss in the first nine months of 2024 was \u003cstrong\u003e$48.9 million\u003c\/strong\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cbr\u003e\u003ch2\u003eBenson Hill, Inc. (BHIL) - VRIO Analysis: 8. Specialty Food Grade Portfolio Foundation\n\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eValue:\u003c\/strong\u003e Provides a secondary, higher-value market stream beyond animal feed, targeting human consumption ingredients with differentiated traits.\u003c\/p\u003e\n\u003cp\u003eProprietary revenues for the full year ended December 31, 2023, excluding the Fresh business divestiture, were \u003cstrong\u003e$110.0 million\u003c\/strong\u003e, representing an increase of \u003cstrong\u003e52 percent\u003c\/strong\u003e year-over-year. The Global Soy Protein Ingredients Market was valued at \u003cstrong\u003eUSD 7.6 Billion in 2022\u003c\/strong\u003e and is projected to reach \u003cstrong\u003eUSD 14.9 Billion by 2032\u003c\/strong\u003e. The plant-based meat segment TAM opportunity was projected to reach \u003cstrong\u003e$140 billion by 2029\u003c\/strong\u003e.\u003c\/p\u003e\n\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2021 Data\u003c\/th\u003e\n\u003cth\u003e2023 Data (Full Year)\u003c\/th\u003e\n\u003cth\u003eQ3 2024 Data\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eContracted Proprietary Soybean Acres\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003e70,000\u003c\/strong\u003e (2021 crop year)\u003c\/td\u003e\n\u003ctd\u003eN\/A\u003c\/td\u003e\n\u003ctd\u003eN\/A\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eProprietary Revenue Growth (YoY)\u003c\/td\u003e\n\u003ctd\u003eN\/A\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003e52 percent\u003c\/strong\u003e increase\u003c\/td\u003e\n\u003ctd\u003eN\/A\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eProprietary Revenue Amount\u003c\/td\u003e\n\u003ctd\u003eN\/A\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$110.0 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eN\/A\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eQ3 Revenue Amount\u003c\/td\u003e\n\u003ctd\u003eN\/A\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003e$23.5 million\u003c\/strong\u003e (Q3 2023)\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003e$34.1 million\u003c\/strong\u003e (Q3 2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003e\u003cstrong\u003eRarity:\u003c\/strong\u003e Moderate; while many soy processors exist, the ability to supply specialty ingredients derived from their unique genetics is less common.\u003c\/p\u003e\n\u003cp\u003eContracted acres of proprietary soybean varieties grew by approximately \u003cstrong\u003e133 percent\u003c\/strong\u003e year-over-year, from \u003cstrong\u003e30,000 acres\u003c\/strong\u003e in the 2020 crop year to \u003cstrong\u003e70,000 acres\u003c\/strong\u003e in the 2021 crop year. The initial TruVail product line included high protein soy flour, a less processed equivalent to soy protein concentrate (SPC).\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eImitability:\u003c\/strong\u003e Moderate; requires both the genetics and the necessary processing knowledge, which was partially divested but the IP remains.\u003c\/p\u003e\n\u003cp\u003eThe acquired assets included more than \u003cstrong\u003e350 patents\u003c\/strong\u003e issued or pending. Proprietary Ultra-High Protein (UHP) soy varieties are designed to require up to \u003cstrong\u003e70 percent less water\u003c\/strong\u003e and up to \u003cstrong\u003e50 percent less carbon dioxide equivalent\u003c\/strong\u003e to produce than US-sourced SPC.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eProprietary genetics enable:\n\u003cul\u003e\n\u003cli\u003eHigher protein content.\u003c\/li\u003e\n\u003cli\u003eReduced off-flavors in yellow pea varieties.\u003c\/li\u003e\n\u003cli\u003eBenefits of omega-9 fatty acids.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eOrganization:\u003c\/strong\u003e Moderate; this was a stated area for expansion for the acquiring entity, showing inherent value in the existing product candidates.\u003c\/p\u003e\n\u003cp\u003eThe entity acquiring the assets stated a focus on \u003cstrong\u003eexpanding market position in its specialty food grade portfolio\u003c\/strong\u003e. The company reported \u003cstrong\u003e$48.9 million\u003c\/strong\u003e in cash and marketable securities at the end of 2023, following debt retirement actions. The company's Adjusted EBITDA loss improved by more than \u003cstrong\u003e40 percent\u003c\/strong\u003e year-over-year for the full year 2023.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCompetitive Advantage:\u003c\/strong\u003e Temporary; it requires further development and scaling outside the core feed focus.\u003c\/p\u003e\n\u003cp\u003eReported revenues for the full year 2023 were \u003cstrong\u003e$473.3 million\u003c\/strong\u003e, an increase of \u003cstrong\u003e24 percent\u003c\/strong\u003e, while the TTM revenue as of late 2024 was reported as \u003cstrong\u003e$0.20 Billion USD\u003c\/strong\u003e. The company is transitioning to an asset-light licensing model, with Q3 2024 revenue reflecting residual grain sales.\u003c\/p\u003e\n\n\u003cbr\u003e\u003ch2\u003eBenson Hill, Inc. (BHIL) - VRIO Analysis: 9. Unique Soy Germplasm Library\n\u003c\/h2\u003e\n\n\u003ch3\u003eValue\u003c\/h3\u003e\n\u003cp\u003eThe foundational biological material that feeds the CropOS® platform and the entire breeding pipeline, representing decades of biological diversity capture. This asset enables the development of varieties with protein gains of \u003cstrong\u003e2%\u003c\/strong\u003e over the previous generation in third-generation Ultra High Protein Low Oligosaccharides, non-GMO soybeans. \u003cstrong\u003eBenson Hill\u003c\/strong\u003e is strategically positioned to drive seed innovation in broadacre opportunities for the aquaculture, pet food, swine and poultry markets – some \u003cstrong\u003e90 percent\u003c\/strong\u003e of the soy market by leveraging deep insights on its proprietary soybean germplasm. \u003cstrong\u003eBenson Hill\u003c\/strong\u003e previously offered about a dozen soybean seed varieties and expanded its commercially available portfolio for the 2024 planting season to more than \u003cstrong\u003e20 varieties\u003c\/strong\u003e across several relative maturity groups.\u003c\/p\u003e\n\n\u003ch3\u003eRarity\u003c\/h3\u003e\n\u003cp\u003eHigh; the diversity and specific characteristics within the library are unique to the company's historical collection efforts. The company is leveraging genomic data on \u003cstrong\u003e20,000 recognized soybean varieties\u003c\/strong\u003e, including proprietary high protein populations for North America, within the CropOS platform.\u003c\/p\u003e\n\n\u003ch3\u003eImitability\u003c\/h3\u003e\n\u003cp\u003eVery High; replicating a diverse, well-characterized germplasm library is extremely difficult and time-consuming. The company expects to expand its portfolio of seed innovations again in \u003cstrong\u003e2025\u003c\/strong\u003e to offer \u003cstrong\u003etwo dozen varieties\u003c\/strong\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eOrganization\u003c\/h3\u003e\n\u003cp\u003eHigh; this is the raw material that makes the technology and genetics valuable; it was explicitly part of the acquired assets. The company expects to double its seed portfolio by \u003cstrong\u003e2025\u003c\/strong\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eCompetitive Advantage\u003c\/h3\u003e\n\u003cp\u003eSustained; biological assets like germplasm are long-term, hard-to-replicate resources. The company has discovered ways to boost soy protein by \u003cstrong\u003e8 to 10 percentage points\u003c\/strong\u003e over commodity.\u003c\/p\u003e\n\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003ctd\u003eGermplasm\/Breeding Metric\u003c\/td\u003e\n\u003ctd\u003eValue\u003c\/td\u003e\n\u003ctd\u003eContext\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eAcquired Genetics Year\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e2019\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eHigh-protein soybean genetics acquired\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eVarieties Offered (2024)\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e\u0026gt;20\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eCommercially available soybean varieties\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eProjected Varieties (2025)\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eTwo dozen (24)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003ePortfolio expansion target\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eProtein Gain vs. Previous Gen\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e2%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eThird-generation Ultra High Protein varieties\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eYield Gap vs. Commodity\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e3 to 5 bushels per acre\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eCompared with commodity GMO soybeans\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTotal Varieties Modeled in CropOS\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e20,000\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eRecognized soybean varieties in data library\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCandidate Varieties Advanced (Since 2021)\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e\u0026gt;24,000\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eDesigned and advanced through CropOS\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eThe following represents a snapshot of the latest reported financial figures, relevant to assessing the entity's structure and liquidity:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eCash and Marketable Securities (as of September 30, 2024): \u003cstrong\u003e$14.4 million\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eTotal Current Assets (Q3 2024): \u003cstrong\u003e$48,165\u003c\/strong\u003e (in thousands).\u003c\/li\u003e\n\u003cli\u003eFree Cash Flow Loss (First Nine Months of 2024): \u003cstrong\u003e$48.9 million\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eProperty and Equipment, net (Q3 2024): \u003cstrong\u003e$21,143\u003c\/strong\u003e (in thousands).\u003c\/li\u003e\n\u003cli\u003eFinance Lease Right-of-Use Assets, net (Q3 2024): \u003cstrong\u003e$53,813\u003c\/strong\u003e (in thousands).\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"dcf.fm","offers":[{"title":"Default Title","offer_id":45516124782741,"sku":"bhil-vrio-analysis","price":7.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0630\/5189\/0837\/files\/bhil-vrio-analysis.png?v=1740152570","url":"https:\/\/dcf-model.com\/pt\/products\/bhil-vrio-analysis","provider":"AI-Powered Discounted Cash Flow Model Templates","version":"1.0","type":"link"}